ArcherDX Blog ArcherDX to Present at Cowen’s 2020 Liquid Biopsy Summit
ArcherDX to Present at Cowen’s 2020 Liquid Biopsy Summit BOULDER, Colo., September 17, 2020 /PRNewswire/ – ArcherDX, Inc. today announced that Jason Myers, Ph.D., Chief Executive […] The post ArcherDX to Present at Cowen’s 2020 Liquid Biopsy Summit appeared first on .
Read full article »
ArcherDX is a bioinformatics company that develops and commercializes NGS-based gene fusion detection assays for oncology applications.
Read more